Why Need to Watch: Sequenom Inc. (NASDAQ:SQNM), Medical Transcription Billing, Corp. (NASDAQ:MTBC), Zafgen, Inc. (NASDAQ:ZFGN), Boston Properties Inc. (NYSE:BXP), Stericycle, Inc. (NASDAQ:SRCL)

Sequenom, Inc. (NASDAQ: SQNM) today reported total revenues of $32.8 million for the second quarter of 2015, a decrease of 18% compared to revenues of $39.8 million for the second quarter of 2014. Revenues for the second quarter of 2014 included approximately $6.1 million of incremental “catch-up” payments from payors for services performed in prior periods, as well as the incremental change for the conversion from cash to accrual accounting for certain payors. Sequenom Inc. (NASDAQ:SQNM) belongs to Healthcare sector. Its net profit margin is 20.30% and weekly performance is -16.07%. On last trading day company shares ended up $2.35. Sequenom Inc. (NASDAQ:SQNM) distance from 50-day simple moving average (SMA50) is -24.55%.

Medical Transcription Billing Corp (NASDAQ:MTBC) was upgraded by Zacks from a “sell” rating to a “hold” rating in a note. Medical Transcription Billing, Corp. (NASDAQ:MTBC) shares increased 5.86% in last trading session and ended the day at $2.35. MTBC Gross Margin is 40.60% and its return on assets is -27.80%. Medical Transcription Billing, Corp. (NASDAQ:MTBC) quarterly performance is 8.80%.

Zafgen, Inc. (NASDAQ:ZFGN) is scheduled to report quarterly earnings on 12 August 2015. On 06 August, Zafgen, Inc. (NASDAQ:ZFGN) shares fell -1.10% and was closed at $37.88. Zafgen, Inc. (NASDAQ:ZFGN) year to date (YTD) performance is 22.83%.

Boston Properties Inc. (NYSE:BXP) on 29 July, reported second-quarter fund from operations of $208.7 million, up 0.8 percent from $207 million in the year-ago period, and $79.5 million in net income available to shareholders, up 3.8 percent from a year prior. Boston Properties Inc. (NYSE:BXP) ended the last trading day at $120.95. Company weekly volatility is calculated as 1.73% and price to cash ratio as 13.83. Boston Properties Inc. (NYSE:BXP) showed a weekly performance of -1.94%.

Stericycle Inc (NASDAQ:SRCL) on Thursday reported second-quarter net income of $60.4 million or $0.70 per share, up from $81.9 million or $0.95 per share last year. Adjusted earnings for the quarter rose to $1.14 per share from $1.04 per share last year. Revenues for the quarter were $715.7 million, up 11.7 percent from $640.8 million last year. Stericycle, Inc. (NASDAQ:SRCL) shares fell -1.00% in last trading session and ended the day at $141.86. SRCL Gross Margin is 42.30% and its return on assets is 7.30%. Stericycle, Inc. (NASDAQ:SRCL) quarterly performance is 6.58%.

Leave a Reply

Your email address will not be published. Required fields are marked *